Tuesday
December 8, 202
4:55 - 5:40 PM CST

Kolon TissueGene

TG-C, a Potential Novel Disease Modifying Gene and Cell Therapy
Targeting Various Orthopedic Diseases and Degenerative Disorders

Presenter:       Matthew Kiser, MBA

Moderator:      Michael A. Mont, MD

TG-C is a cell-mediated gene therapy that is currently under development in the United States for the treatment of osteoarthritis of the knee, it is an advanced cell therapies targeting various orthopedic diseases and degenerative disorders

Learning Objectives:
      1.     Overview of the TG-C
      2.     Target indications
      3.     Growth Potential

Tuesday
December 8, 2020
5:40 - 6:25 PM CST

DePuy Synthes

DePuy

Unleashing the Power of ATTUNE®


Presenters:       David F. Dalury, MD
                          Ryan Nunley, MD

Tuesday,
December 8
8:35 - 9:20 PM CST

Zimmer Biomet

ZimmerBiomet_2020

ROSA® Knee – Efficiently Adapting Robotics to Your Surgical Workflow

Presenters:       Nathan L. Cafferky, MD, FAAOS
                          Timothy E. Ekpo, DO

Moderator:       Adolph V. Lombardi, Jr., MD, FACS

In this session, a ROSA faculty panel will share their experiences with robotic adoption and highlight several TKA surgical workflow pathways

Learning Objectives:
      1.     Gain an understanding of the application of ROSA robotics in TKA
      2.     Appreciate the benefits of objective soft tissue data for personalized approach to TKA
      3.     Identify surgical workflow pathways within ROSA® Knee

Wednesday,
December 9, 2020
5:40 - 6:25 PM CST

Quil Health

Quil

Leveraging Patient Engagement Technology to
Improve Both Patient and Employee Satisfaction

Presenter:        Carina Edwards, CEO of Quil
                            Leveraging Patient Engagement Technology to Improve Both Patient and Employee Satisfaction

Moderator:       Arjun Saxena, MD

How to leverage a digital patient engagement solution to streamline and enhance the experience while improving both patient satisfaction and employee satisfaction.

Learning Objectives:
      1.     Ideas to define and differentiate your patient experience with helpful resources and
                     tools that patients are demanding today.
      2.     Build on the strategy for patient engagement that will be sustainable and produce results
      3.     Learn how industry-leading organizations are using Quil to improve health outcomes and operational efficiency

Wednesday
December 9, 2020
8:35 – 9:20 PM CST

Ceras Health, Inc.

Ceras-Health-Logo

Establish New Practice Revenue Streams from Digital Technologies
and Connected Patient Experiences

Presenter:       Udaya Devineni,  President & Chief Executive Officer

Moderator:      Michael A. Mont, MD

Create new revenue streams through improved outcomes from pre-op, surgery, rehab, and follow-ups with remote monitoring technologies, transitional care and intervention services.

Increase patient follow-ups post-surgery with innovative wear and forget devices that automatically transmit activities of daily living for Care Team review and intervention.

Establish digital contacted experience with patients to drive long term patient engagement and increase revenues.

Learning Objectives:
      1.      How RPM Technologies can increase revenue
      2.     Digital Connected Experience
      3.     Patient engagement and outcomes analytics

CeraIsAddon

Thursday,
December 10, 2020
5:40 – 6:25 PM CST

Pacira BioSciences, Inc.

PACIRA Biosciences_2020

Cryoanalgesia as Part of a Multimodal Solution to Manage TKA Pain

Presenters:       Sean McMillan, DO
                             Cryoanalgesia as Part of a Multimodal Solution to Manage TKA Pain
                          William M. Mihalko, MD, PhD
                             Cryoanalgesia as Part of a Multimodal Solution to Manage TKA Pain

Moderator:        Michael A. Mont, MD

This session will feature an overview of cryoanalgesia, clinical application and discussion on how the iovera° technology can improve post-surgical recovery.

Learning Objectives:
      1.      Evolution of cryoanalgesia and the iovera° Technology
      2.     How iovera can decrease opioids used by patients post-TKA
      3.     Clinical outcomes with iovera°

Thursday
December 10, 2020
8:35 – 9:20 PM CST

OrthoSensor, Inc.

Ortho

VERASENSE ™ – What Is It and How Do You Use It? Improved Clinical Outcomes, Significant Cost Savings

Presenters:       Kenneth A. Gustke, M.D
                            VERASENSE™ – What Is It and How Do You Use It
                          Alexander Sah, MD
                            VERASENSE™ Improves Short-Term Clinical Outcomes
                          Martin W. Roche, MD
                            VERASENSE™ Provides Cost Savings in the 90-day Bundle

Moderator:        Michael Conditt, PhD

Discussing VERASENSE Short Term Outcomes from a Randomized Study

Learning Objectives:
      1.      Learn How a Balanced Knee Affects Short-Term Outcome Measurements
      2.     Discuss the Adoption of VERASENSE Technology and Short Term Outcomes
      3.     Explore Whether Quantifying Knee Balance is Cost-Effective

Friday
December 11
7:10 - 7:55 AM CST

Zimmer Biomet

ZimmerBiomet_2020

Optimizing Joint Arthroplasty in the ASC

Presenter:       Nicholas Frisch, MD

Moderator:      Sharon Edwards, Zimmer Biomet MedEd Manager

Are you comfortable performing total hip arthroplasty using the anterior approach, but haven't made the leap to performing them in an outpatient setting? As outpatient total hip procedures become increasingly common, it's important to set yourself up for success when you transition this technique into your ASC. Join Dr. Nicholas Frisch to review his top considerations for introducing the Anterior hip approach into an ASC setting.

Learning Objectives:
      1.      Understand common challenges associated with introducing the Anterior Total Hip procedure into an ASC setting.
      2.     Understand the value standardization drives in maximizing efficiencies in the ASC.

Friday
December 11, 2020
12:05-12:50 PM CST

DePuy Synthes

DePuy

Utilizing Technology to Address Pelvic Tilt

Presenters:       Charles DeCook, MD
                          Atul Kamath, MD
                          Jesse Otero, MD

Join Dr. DeCook for Opening Remarks Pelvic Tilt Made Simple, followed by introduction to PINNACLE Dual Mobility presented by Dr. Otero then discussion led by Dr. Katah

Learning Objective:
      Talking through Pelvic Tilt and how to help address this problem and also giving a clinical overview of modular Dual Mobility.

Saturday
December 12, 2020
7:10 - 7:55 AM CST

Ethicon

Ethicon

The Use of Technologies for Wound Management Following Hip and Knee Arthroplasty

Presenters:       Ryan M. Nunley, MD
                            
 The Use of Technologies for Wound Management Following Hip and Knee Arthroplasty
                          Michael A. Mont, MD
                             The Use of Technologies for Wound Management Following Hip and Knee Arthroplasty

Moderator:        Michael A. Mont, MD

Wound closure techniques for the current times for hips and knees arthroplasty: optimizing post-operative patient care / telemedicine / addressing infections

Learning Objectives:
      1.      Differentiative wound closure techniques for hip and knee arthroplasty
      2.     Optimizing post-operative patient care
      3.     Using telemedicine to your advantage

Saturday
December 12, 2020
12:05 - 12:50 PM CST

3M

3M-KCI_2020

Latest Clinical Evidence of Advanced Incision Management in High Risk Arthroplasty Patients

Presenters:       Carlos Higuera-Rueda, MD
                             Decreased 90-Day Surgical Site Complication Rates with Closed Incision Negative Pressure
                                 Therapy after Revision Knee Arthroplasty: A Randomized Trial

                          John A. Cooper, MD
                              A Risk-Stratification Algorithm to Reduce Superficial Surgical Site Complications in Primar
                                 Hip and Knee Arthroplasty


Moderator:        Janine Hartfield

Join Dr. Carlos Higuera and Dr. John Cooper as they present the results of their respective studies which show a reduction of surgical site complications (SSC) and improved functional outcomes in high risk arthroplasty patients who receive closed-incision negative pressure therapy (ciNPT).

Learning Objectives:
      1.      Share how risk-stratification algorithms help identify patients at risk for superficial SSCs and leveraging ciNPT
                    reduces the risk profile and optimizes post-operative outcomes
      2.     Review the latest clinical evidence demonstrating significantly lower 90-day SSC rates using ciNPT
                    vs. standard of care
      3.     Engage and interact with the primary authors in a live Q&A discussion on their studies and findings